Hereditary Sensory and Autonomic Neuropathy Type 2 Overview
Learn About Hereditary Sensory and Autonomic Neuropathy Type 2
- Hereditary sensory and autonomic neuropathy type 2
- Giaccai type acroosteolysis
- HSAN2
- Hereditary sensory neuropathy type 2
- Hereditary sensory radicular neuropathy, recessive form
- Morvan disease
- Neurogenic acroosteolysis
- Neuropathy, congenital sensory
- Neuropathy, progressive sensory, of children
Amirhassan Bahreman is a Neurologist in La Mesa, California. Dr. Bahreman and is rated as a Distinguished provider by MediFind in the treatment of Hereditary Sensory and Autonomic Neuropathy Type 2. His top areas of expertise are Congenital Insensitivity to Pain with Anhidrosis, Hereditary Sensory and Autonomic Neuropathy Type 2, Infantile Axonal Neuropathy, and Genetic Epilepsy with Febrile Seizures Plus (GEFS+).
Sharp Rees-Stealy Medical Group Inc
Justin Dominick is a Neurologist in San Diego, California. Dr. Dominick and is rated as an Experienced provider by MediFind in the treatment of Hereditary Sensory and Autonomic Neuropathy Type 2. His top areas of expertise are Memory Loss, REM Behavior Disorder, Myasthenia Gravis, and Subdural Hematoma.
William Mobley is a Neurologist in San Diego, California. Dr. Mobley and is rated as an Advanced provider by MediFind in the treatment of Hereditary Sensory and Autonomic Neuropathy Type 2. His top areas of expertise are Down Syndrome, Dementia, Alzheimer's Disease, and Huntington Disease.
Summary: The study will collect clinical information from patients with FD and allow them to give blood to help develop biological markers of the disease to aid diagnosis and treatment. This is a non-invasive, non-interventional, observation study that poses only minimal risk for participants. The study will document the clinical features of patients with FD overtime by storing their routine clinical test ...
Summary: This is a pilot open-label study to evaluate the feasibility of conducting a clinical trial using sublingual dexmedetomidine sublingual film to treat hyperadrenergic autonomic crises in patients with Familial Dysautonomia at home. The primary aims are to examine the feasibility of performing a clinical trial using dexmedetomidine at home to terminate autonomic crisis, and refine the interventions ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center